FDA Notices of Judgment Collection, 1908-1966

Search

Start Over Titles 3322. Misbranding of Dexedrine Sulfate tablets and Benzedrine Sulfate tablets. U. S. v. John C. Booth (Booth Prescription Pharmacy). Plea of nolo contendere. Fine $100 on each of first 2 counts of information; sentence suspended on remaining 2 counts. ✖Remove constraint Titles: 3322. Misbranding of Dexedrine Sulfate tablets and Benzedrine Sulfate tablets. U. S. v. John C. Booth (Booth Prescription Pharmacy). Plea of nolo contendere. Fine $100 on each of first 2 counts of information; sentence suspended on remaining 2 counts. Defendants John C. Booth, trading as the Booth Prescription Pharmacy, Portales, N. Mex. ✖Remove constraint Defendants: John C. Booth, trading as the Booth Prescription Pharmacy, Portales, N. Mex. Issue Dates May 1951 ✖Remove constraint Issue Dates: May 1951 Adjudicating Courts District of New Mexico ✖Remove constraint Adjudicating Courts: District of New Mexico

Refine by:

  • 3322. Misbranding of Dexedrine Sulfate tablets and Benzedrine Sulfate tablets. U. S. v. John C. Booth (Booth Prescription Pharmacy). Plea of nolo contendere. Fine $100 on each of first 2 counts of information; sentence suspended on remaining 2 counts.1

  • John C. Booth, trading as the Booth Prescription Pharmacy, Portales, N. Mex.1